hta in poland wojciech matusewicz, ph.d., m.d. – director iga lipska, m.d. – head of hta...
TRANSCRIPT
![Page 1: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/1.jpg)
HTA in Poland
Wojciech Matusewicz, Ph.D., M.D. – Director
Iga Lipska, M.D. – Head of HTA Department
Agency for Health Technology Assessment in Poland AHTAPol
![Page 2: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/2.jpg)
1. Poland and Polish health care system
2. AHTAPol legal basis
3. AHTAPol tasks and activities
4. AHTAPol analytic team
5. Drug reimbursement / HTA
![Page 3: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/3.jpg)
Poland
![Page 4: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/4.jpg)
Polish health care system
• Centralised• Health insurance system - taxes• National Health Fund (NHF)• 16 regional branches • NHF concludes contracts with health service providers• NHF budget for 2009 is 56,8 billion PLN (14 billion EURO)• Drug reimbursement - 7,3 billion PLN (12,9%)• Therapeutic drug programs - 1,3 billion PLN (2%)• Total public spending about 4% GDP.
![Page 5: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/5.jpg)
AHTAPol - Legal basis
• Created in 2005 (Ordinance by MoH Sept 2005)• The possible lowest legal act• So far updated every year:
June 2006 Sept 2007 Sept 2008
• Steps undertaken to prepare the Law on AHTAPol establishment
• The Bill prepared and submitted for Parliament work• Planned to come into force in 2009 (June?)
![Page 6: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/6.jpg)
AHTAPol – tasks and activities
• Still a lot of discussions• Which activities should be performed by this institution• Which model of the Agency should be implemented
Light Heavy (limitations) Mixed
• International collaboration! EUnetHTA, INAHTA, HTAi, ISPOR, GIN
• Drug reimbursement list (Transparency Directive!)• Therapeutic programmes• Non – drug technologies
![Page 7: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/7.jpg)
AHTAPol - tasks and activities
0 0 0
7
5
1
40
23
3
0
5
10
15
20
25
30
35
40
2006 2007 2008
drugs-reimbursement list
drugs-therapeutic programs
non-drug technologies
![Page 8: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/8.jpg)
• Horizon scanning/new and emerging technologies
Early warning/awarness system
• Stakeholders’ involvement• Screenning programmes• Education in HTA
Cascading/distance learning programmes
• Registries• Clinical Practise Guidelines• Eastern Dimension Capacity Building
AHTAPol – FUTURE tasks and activities
![Page 9: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/9.jpg)
AHTAPol - Analytic team
• Build a strong team - one of the biggest tasks for a new institution
• Motivation system created to maintain people working in Agency Continuous trainings International collaboration Professional development
• Money, money, money…• Maybe not only : ))• Salaries - public administration v. private sector
![Page 10: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/10.jpg)
AHTAPol - Analytic team POSSIBILITIES
• EU funded project 2 million EURO• Twinning project Poland - France (Oct 2006 - Apr 2008)• 2 Components: • Institutional - proposals of structural and procedural
improvements for AHTAPol and other institutions• Trainings in EBM and HTA
DOERS – about 30 people USERS – about 300 people Training for trainers – about 15 people trainned 7 internships 2 months long CORE of THE TEAM 1 internship 6 months long
![Page 11: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/11.jpg)
AHTAPol - Analytic team
3
9
13
23
0
5
10
15
20
25
June 2006 Dec 2006 Dec 2007 Dec 2008
Analysts
![Page 12: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/12.jpg)
Drug reimbursement / HTA
• Drug reimbursement list• Therapeutic programmes• Revision of applications
Submitted by the industry
• Assessment of analysis in terms of credibility and quality Clinical effectiveness Cost effectiveness
Budget impact analysis • Consultative Council (CC) – the role
![Page 13: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/13.jpg)
CC recommendation types
• “Finance” • “Finance temporarily, provided that the data are
gathered to a final decision”• ”Finance provided that some precisely criteria are met
or in particular indications” • “Finance provided that a cost-effective way of financing
was assured” • “Not to finance” • “Increase financing” • “Decrease financing” • ”Not to change financing”
![Page 14: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/14.jpg)
HTA in decision making process
• Assessment and Appraisal• Completely separated processes• Assessment/Revision of industry submission – by
Analytic Team• Appraisal – by Consultative Council • CC recommendation• Decision making – Ministry of Health
![Page 15: HTA in Poland Wojciech Matusewicz, Ph.D., M.D. – Director Iga Lipska, M.D. – Head of HTA Department Agency for Health Technology Assessment in Poland AHTAPol](https://reader036.vdocuments.mx/reader036/viewer/2022082712/56649f345503460f94c51086/html5/thumbnails/15.jpg)
• Thank you for your attention
• Questions???